CONCLUSIONS: Providing K-care during RSE in preterm infants may potentially reduce pain-related stress, cortisol and inflammatory responses. →

CONCLUSION: Although conducted during the COVID-19 pandemic in a potentially vulnerable elderly population and affected by geopolitical disruption in Ukraine, mitigation measures minimised the overall impact of these events. FYB203 demonstrated therapeutic equivalence to reference aflibercept in patients with nAMD, supporting similar clinical performance across all approved indications. →

CONCLUSION: IBI324 was well tolerated with evidence of functional and anatomical improvement in patients with DME. →

CONCLUSIONS: A definitive randomised controlled trial of SLH post-PR appears feasible, with acceptable uptake and completion rates. →

CONCLUSIONS: Topical efinaconazole 10% showed favorable efficacy/safety in White, Asian, and Black participants with mild-to-moderate onychomycosis. Results were generally consistent with the overall phase 3 populations and position efinaconazole as an efficacious treatment for patients, regardless of race. &nbsp. →

CONCLUSIONS: A new multimodal skin tone correcting serum demonstrated significant improvements in MASI scores and in the appearance of skin texture and dullness. Significant improvements were also achieved in participants using both the skin tone correcting serum and double-conjugated retinoid/AHA cream. Participants reported high levels of satisfaction over 12 weeks. &nbsp. →

CONCLUSION: These data support the integration of Thiamidol-containing formulations into existing skin regimens for individuals with facial hyperpigmentation. &nbsp. →

CONCLUSION: These findings suggest that malassezin shows comparable efficacy to the gold standard, hydroquinone. Our results further support malassezin as a promising new treatment for patients with melasma. &nbsp. →